Evidence map›Paper›PMID 17682046›Full record

ArticleInfection and immunity2007

Rapid elimination of Toxoplasma gondii by gamma interferon-primed mouse macrophages is independent of CD40 signaling.

Yanlin Zhao, Douglas Wilson, Suzanne Matthews, George S Yap

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Influence ofFrontiers in immunology · 2021
    Review
  3. The Host Autophagy DuringFrontiers in microbiology · 2020
    Review
  4. Interplay BetweenFrontiers in cellular and infection microbiology · 2019
    Review
  5. The Interplay of Host Autophagy and Eukaryotic Pathogens.Frontiers in cell and developmental biology · 2018
    Review
  6. Memory-phenotype CD4Science immunology · 2017
    Article
  7. LAP-like process as an immune mechanism downstream of IFN-γ in control of the human malaria Plasmodium vivax liver stage.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yanlin ZhaoDepartment of Molecular Microbiology and Immunology, Warren Alpert Medical School, Brown University, Providence, RI 02912, USA.
Douglas Wilson
Suzanne Matthews
George S Yap
Brown University · US

Funding

Regulation of Type1 Immunity to ToxoplasmaR01AI050618 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI YAP, GEORGE S. · 2002 to 2010
$2.3M
NIAID NIH HHS AI-50618NIAID NIH HHS R01 AI050618
6 · The paper itself

Abstract

Autophagy has been implicated in the intracellular destruction of Toxoplasma gondii by primed macrophages following gamma interferon (IFN-gamma) activation of p47 GTPases. CD40 ligation has also been shown to trigger autophagic elimination of T. gondii independent of IFN-gamma and p47 GTPases. Here we demonstrate that IFN-gamma/p47 GTPase-dependent elimination of T. gondii by strain CPS vaccine-primed macrophages is independent of CD40/tumor necrosis factor signaling. Similar to wild-type controls, both CD40-deficient and tumor necrosis factor receptor 1/2 (TNFR1/2)-deficient macrophages can efficiently eliminate invaded strain GFP-PTG and restrain its replication following priming. In contrast, macrophages from mice lacking the IFN-gamma receptor gene neither clear the parasites nor repress their proliferation. Thus, CD40 and IFN-gamma-induced pathogen elimination might represent two independent resistance pathways, the latter of which plays a primary role in anti-Toxoplasma immunity in mice.

Indexed as

AnimalsCD40 AntigensCells, CulturedFemaleInterferon-gammaMacrophagesMaleMiceMice, Inbred C57BLMice, KnockoutReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IISignal TransductionToxoplasmaCD40 AntigensInterferon-gammaReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IITnfrsf1a protein, mouse

Identifiers

PMID17682046
PMCPMC2044553
OpenAlexW2120605545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.